Long-Term Biased &bgr;-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy
暂无分享,去创建一个
B. Russell | B. Wolska | C. Cowan | R. Solaro | D. Ryba | Jieli Li | B. Wolska | R. Solaro | Conrad L. Cowan
[1] B. Wolska,et al. N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy. , 2015, American journal of physiology. Heart and circulatory physiology.
[2] Hong-da Liu,et al. Phospho-selective mechanisms of arrestin conformations and functions revealed by unnatural amino acid incorporation and 19F-NMR , 2015, Nature Communications.
[3] J. Violin,et al. Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model. , 2015, Cardiovascular research.
[4] K. Dodge-Kafka,et al. RSK3: A regulator of pathological cardiac remodeling , 2015, IUBMB life.
[5] P. Ponikowski,et al. Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure). , 2015, JACC. Heart failure.
[6] Jonathan P. Davis,et al. Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation. , 2014, Journal of molecular and cellular cardiology.
[7] M. C. Villa-Abrille,et al. Physiological cardiac hypertrophy: critical role of AKT in the prevention of NHE-1 hyperactivity. , 2014, Journal of molecular and cellular cardiology.
[8] Henggui Zhang,et al. Pak1 Is Required to Maintain Ventricular Ca 2+ Homeostasis and Electrophysiological Stability Through SERCA2a Regulation in Mice , 2014, Circulation. Arrhythmia and electrophysiology.
[9] Ryan T. Strachan,et al. Allosteric Modulation of β-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch* , 2014, The Journal of Biological Chemistry.
[10] Steven B Marston,et al. Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca2+-sensitivity in the pathogenesis of cardiomyopathy , 2014, Front. Physiol..
[11] Jonathan P. Davis,et al. Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment. , 2014, Journal of molecular and cellular cardiology.
[12] B. Mckittrick,et al. Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery. , 2014, Journal of medicinal chemistry.
[13] R. Lefkowitz,et al. Recent developments in biased agonism. , 2014, Current opinion in cell biology.
[14] Stefan Kochanek,et al. The Transcription Factor Serum Response Factor Stimulates Axon Regeneration through Cytoplasmic Localization and Cofilin Interaction , 2013, The Journal of Neuroscience.
[15] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[16] M. Kapiloff,et al. p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in α-tropomyosin Glu180Gly transgenic mice. , 2013, American journal of physiology. Heart and circulatory physiology.
[17] J. Violin,et al. The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium. , 2013, American journal of physiology. Heart and circulatory physiology.
[18] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.
[19] J. Violin,et al. First Clinical Experience with TRV027: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers , 2013, Journal of clinical pharmacology.
[20] D. Ward,et al. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity. , 2013, Cardiovascular research.
[21] Z. Derewenda,et al. The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility , 2013, PloS one.
[22] C. D. dos Remedios,et al. Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes. , 2013, American journal of physiology. Heart and circulatory physiology.
[23] A. Hanauer,et al. Anchored p90 Ribosomal S6 Kinase 3 Is Required for Cardiac Myocyte Hypertrophy , 2013, Circulation research.
[24] Jeroen A. A. Demmers,et al. GSK3&bgr; Phosphorylates Newly Identified Site in the Proline-Alanine–Rich Region of Cardiac Myosin–Binding Protein C and Alters Cross-Bridge Cycling Kinetics in Human: Short Communication , 2012, Circulation research.
[25] M. Swanson,et al. Myosin Light Chain Phosphorylation Is Critical for Adaptation to Cardiac Stress , 2012, Circulation.
[26] Shamim A. K. Chowdhury,et al. Maintenance of adult cardiac function requires the chromatin factor Asxl2. , 2012, Journal of molecular and cellular cardiology.
[27] J. Violin,et al. β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury. , 2012, American journal of physiology. Heart and circulatory physiology.
[28] D. Szczesna‐Cordary,et al. The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts , 2012, Journal of cellular and molecular medicine.
[29] Kurt Wüthrich,et al. Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by 19F-NMR , 2012, Science.
[30] K. Dodge-Kafka,et al. A-kinase anchoring proteins: scaffolding proteins in the heart. , 2011, American journal of physiology. Heart and circulatory physiology.
[31] Ryan T. Strachan,et al. Distinct Phosphorylation Sites on the β2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of β-Arrestin , 2011, Science Signaling.
[32] Shamim A. K. Chowdhury,et al. Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N. , 2011, American journal of physiology. Heart and circulatory physiology.
[33] R. Lefkowitz,et al. Therapeutic potential of β-arrestin- and G protein-biased agonists. , 2011, Trends in molecular medicine.
[34] Lisa Nguyen,et al. Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance , 2010, Journal of Pharmacology and Experimental Therapeutics.
[35] Olga K Afanasiev,et al. Endogenous Wnt/β-Catenin Signaling Is Required for Cardiac Differentiation in Human Embryonic Stem Cells , 2010, PloS one.
[36] K. Rakesh,et al. β-Arrestin–Biased Agonism of the Angiotensin Receptor Induced by Mechanical Stress , 2010, Science Signaling.
[37] C. D. dos Remedios,et al. Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background. , 2010, Journal of molecular and cellular cardiology.
[38] Q. Lu,et al. Phosphorylation of Cardiac Troponin I at Protein Kinase C Site Threonine 144 Depresses Cooperative Activation of Thin Filaments* , 2010, The Journal of Biological Chemistry.
[39] M. Mayr,et al. Proteomics Analysis of the Cardiac Myofilament Subproteome Reveals Dynamic Alterations in Phosphatase Subunit Distribution* , 2009, Molecular & Cellular Proteomics.
[40] Chulan Kwon,et al. A Regulatory Pathway Involving Notch1/β-Catenin/Isl1 Determines Cardiac Progenitor Cell Fate , 2009, Nature Cell Biology.
[41] R. Lefkowitz,et al. β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation , 2009, Journal of Biological Chemistry.
[42] J. Balligand,et al. β-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation , 2008, Proceedings of the National Academy of Sciences.
[43] G. Boivin,et al. Dilated Cardiomyopathy Mutant Tropomyosin Mice Develop Cardiac Dysfunction With Significantly Decreased Fractional Shortening and Myofilament Calcium Sensitivity , 2007, Circulation research.
[44] W. Birchmeier,et al. &bgr;-Catenin Downregulation Is Required for Adaptive Cardiac Remodeling , 2007, Circulation research.
[45] H. Watkins,et al. The Effect of Mutations in α-Tropomyosin (E40K and E54K) That Cause Familial Dilated Cardiomyopathy on the Regulatory Mechanism of Cardiac Muscle Thin Filaments* , 2007, Journal of Biological Chemistry.
[46] R. Gainetdinov,et al. The Akt-GSK-3 signaling cascade in the actions of dopamine. , 2007, Trends in pharmacological sciences.
[47] Michael S. Cohen,et al. Evidence for Direct Regulation of Myocardial Na+/H+ Exchanger Isoform 1 Phosphorylation and Activity by 90-kDa Ribosomal S6 Kinase (RSK): Effects of the Novel and Specific RSK Inhibitor fmk on Responses to α1-Adrenergic Stimulation , 2007, Molecular Pharmacology.
[48] J. Violin,et al. β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes , 2006, Proceedings of the National Academy of Sciences.
[49] R. Misra,et al. Role of the Serum Response Factor in Regulating Contractile Apparatus Gene Expression and Sarcomeric Integrity in Cardiomyocytes* , 2006, Journal of Biological Chemistry.
[50] H. Watkins,et al. Dilated Cardiomyopathy Mutations in Three Thin Filament Regulatory Proteins Result in a Common Functional Phenotype* , 2005, Journal of Biological Chemistry.
[51] G. King,et al. Role of p90 Ribosomal S6 Kinase (p90RSK) in Reactive Oxygen Species and Protein Kinase C β (PKC-β)-mediated Cardiac Troponin I Phosphorylation* , 2005, Journal of Biological Chemistry.
[52] Marion L Greaser,et al. Method for cardiac myosin heavy chain separation by sodium dodecyl sulfate gel electrophoresis. , 2003, Analytical biochemistry.
[53] R. Lefkowitz,et al. β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation* , 2002, The Journal of Biological Chemistry.
[54] S. Solomon,et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.
[55] D. Moller,et al. Regulation and Interaction of pp90rsk Isoforms with Mitogen-activated Protein Kinases* , 1996, The Journal of Biological Chemistry.
[56] S. Weremowicz,et al. RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation , 1995, Molecular and cellular biology.
[57] R. Edwards,et al. Angiotensin II inhibits glomerular adenylate cyclase via the angiotensin II receptor subtype 1 (AT1). , 1993, The Journal of pharmacology and experimental therapeutics.
[58] M. Anand-Srivastava. Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein. , 1989, Biochemical pharmacology.
[59] K. Jakobs,et al. Mode of inhibition of renin release by angiotensin II. , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[60] S. Morimoto. Sarcomeric proteins and inherited cardiomyopathies. , 2008, Cardiovascular research.
[61] B. Russell,et al. Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein. , 2007, American journal of physiology. Heart and circulatory physiology.
[62] G. King,et al. Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation. , 2005, The Journal of biological chemistry.
[63] Z. Papp,et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. , 2003, Cardiovascular research.
[64] Y. Takeishi,et al. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. , 2002, Cardiovascular research.